Clinical trial
A Comparison Between Glargine and Detemir Insulin in Type 2 Diabetes
NCT00457093 · Diabetes Care Center, Industry · Completed
Key facts
| NCT number | NCT00457093 |
|---|---|
| Title | A Comparison Between Glargine and Detemir Insulin in Type 2 Diabetes |
| Official title | A Double Blind, Randomized, Parallel, Cross-Over Comparision of Glycemic Control Achieved With Once a Day Insulin Glargine Versus Detemir in Type 2 Diabetes |
| Lead sponsor | Diabetes Care Center, Industry |
| Collaborators | Novo Nordisk A/S Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Type 2 Diabetes |
| Intervention type | Drug |
| Interventions | glargine, detemir |
| Enrollment | 35 |
| Start date | Oct 1, 2006 |
| Completion | May 1, 2007 |
| First posted | Apr 5, 2007 |
| Last update posted | Nov 18, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: